|1||NCT01531348||Enrolling by invitation||Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa||
||10||All||18 Years to 65 Years (Adult)||NCT01531348||RP-001||February 2012||December 2020||December 2020||February 10, 2012||August 29, 2017||
|Trial of Oral Valproic Acid for Retinitis Pigmentosa||
||Other / U.S. Fed||
||90||All||18 Years and older (Adult, Senior)||NCT01233609||H-13371||VPA||November 2010||December 2015||December 2015||November 3, 2010||December 1, 2017||December 1, 2017||
† Study has passed its completion date and status has not been verified in more than two years.